Natera, Inc. (NASDAQ:NTRA) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Steven Chapman - Chief Executive Officer Michael Brophy - Chief Financial Officer Alexey Aleshin - Chief Medical Officer John Fesko - Chief Business Officer Conference Call Participants Tejas Savant - Morgan Stanley Puneet Souda - SVB Securities Thomas Peterson - Baird Daniel Brennan - TD Cowen Alexander Nowak - Craig-Hallum Operator Hello. Welcome to Natera's 2023 First Quarter Financial Results Conferen ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37478 NATERA, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 01-0894487 (State or Other ...

× × Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ × × × Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ × × × × × × × x × × × × × × × × × × × × × × × × × × × × 8 natera® × × x × × × Ｘ Ｘ × × × × Ｘ Ｘ × × Ｘ Ｘ × × × × × × × × Fourth Quarter 2022 Earnings Call February 28, 2023 2 × X X X X × × × × × Safe harbor statement These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including: we face numerous uncertainties and challenges in achieving our financial projections and goals; we may be unabl ...

Natera, Inc. (NASDAQ:NTRA) Q4 2022 Results Conference Call February 28, 2022 4:30 PM ET Company Participants Steven Chapman - Chief Executive Officer Michael Brophy - Chief Financial Officer Solomon Moshkevich - GM, Oncology John Fesko - Chief Business Officer Conference Call Participants Andrew Cooper - Raymond James Catherine Schulte - Baird Mark Massaro - BTIG Max Masucci - Cowen & Company Puneet Souda - SVB Securities Julia Qin - JP Morgan Tejas Savant - Morgan Stanley Operator Welcome to Natera's 2022 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37478 NATERA, INC. (Exact Name of Registrant as Specified in its Charter) State or Other Jurisdiction of Incorpora ...

Natera, Inc. (NASDAQ:NTRA) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager, Oncology Conference Call Participants Puneet Souda - SVB Securities Tejas Savant - Morgan Stanley Max Masucci - Cowen Julia Qin - JPMorgan Catherine Schulte - Baird Operator Welcome to Natera's 2022 Third Quarter Financial Results Conference Call. At this time, all participants are i ...

× × × × × × × × x 8 natera × × × Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ × × × × × × Ｘ Ｘ × × × Ⅹ Ｘ Ｘ Ｘ Ｘ Ｘ × × × × Ｘ Ｘ x × x × × × Ｘ Ｘ × × × × × × × x × × × × × × × × × × × × × × × × × Natera, Inc. Investor presentation × × × × × × × × × Third Quarter 2022 Earnings Call November 8, 2022 × × × × × X X × × × × × Safe harbor statement × × × × X X × × This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts cont ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR (650) 249-9090 (Registrant's Telephone Number, Including Area Code) Securities registered pursuant to Section 12(b) of the Act: ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commi ...

Natera, Inc. (NASDAQ:NTRA) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager, Oncology Conference Call Participants Tejas Savant - Morgan Stanley Dave Delahunt - Goldman Sachs Catherine Schulte - Baird Max Masucci - Cowen Puneet Souda - Leerink Julia Qin - JPMorgan Vidyun Bais - BTIG Connor Stevenson - Craig-Hallum Mason Carrico - Stephens Operator Welcome to Nat ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------|-------|-------|-------|-------|---------|-------|-------|-------|-------|-------------|-------| | | | | | | | | | | | | | | | | | | | × × | | × | | × × | × | × | | natera | | | | | × × | | × | | xxxxx | × | | | | | | | | × × | | × | | × × | × | | | | | | | | × × | | × | × | × | X X X | | | | | | | | × × × × | | × × | × × | × × | × × × x x x | | | | | | | | × × | | × | × | × | x | | | | | | | | × × | | × | × | × | x X ...